Skip to main content
. 2021 Jun 10;5(8):bvab110. doi: 10.1210/jendso/bvab110

Table 3.

Response of thyroid nodules to radiofrequency ablation (RFA)

Pre RFA n Post RFA n P value
All Nodules
 Volume (mL) 8 (0.4-54.95) 47 1.89 (0.03-36.35) 47 < 0.0001
 Cosmetic score 4 (0-4) 47 2 (0-4) 45 < 0.0001
NFTNs
 Volume (mL) 10.4 (1.96-31.3) 23 2.09 (0.57-30.2) 23 < 0.0001
 Cosmetic score 4 (3-4) 23 2 (0-4) 21 < 0.0001
 TSH (mIU/L) 1.3 (0.75-3.75) 13 1.3 (0.73-2.7) 13 0.23
 Free T4 (ng/dL) 0.97 (0.8-1.3) 11 0.89 (0.74-1.1) 11 0.02
 On levothyroxine, n 7 22 7 22 1
AFTNs
 Volume (mL) 5.4 (0.4-54.95) 24 1.7 (0.03-36.35 24 0.0001
 Cosmetic score 3.5 (0-4) 24 1 (0-3) 24 < 0.0001
 TSH mIU/L 0.1 (0.01-0.32) 12 0.63 (0.01-1.2) 12 0.0015
 Free T4 (ng/dL) 1.15 (0.9-1.9) 12 0.9 (0.7-1.8) 12 0.01
 On methimazole, n 8 20 6 20 0.74

Data are shown as median with minimum and maximum values in parentheses; n = number of patients. Abbreviations: AFTN, autonomous functional thyroid nodule; NFTN, nonfunctional thyroid nodule; T4, thyroxine; TSH, thyroid-stimulating hormone.